Rheumatology

Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory joint disease characterised by symmetrical inflammation of the peripheral…

The arrival of biologic disease-modifying anti-arthritis drugs (bDMARD) has vastly improved the outcomes of patients

This symposium was developed to consider the future role that AI might play in the management of rheumatic diseases. First, Ignacio Medrano considered the current use of AI in healthcare and its possible future applications.

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an umbrella term for a group of rare, multisystem autoimmune…

AAV are a type of small-vessel necrotising vasculitis that manifest as systemic diseases, with pulmonary; ear, nose, and throat; and renal involvement. The key pathological feature of AAV is the presence of ANCA, which can target two neutrophil antigens, myeloperoxidase (MPO) and proteinase 3 (PR3).

Christopher Edwards | Professor and Consultant Rheumatologist and Honorary Chair of Clinical Rheumatology; Musculoskeletal Research Unit…

Karen Walker-Bone |  Professor and Honorary Consultant in Occupational Rheumatology, University of Southampton; Director, Arthritis Research…

Many patients with rheumatic diseases (RMD) are diagnosed during their childbearing years.1 Historically, females with RMDs were advised to avoid pregnancy due to potential risk to both mother and fetus.